CYP26A1 antibody
Principal name
CYP26A1 antibody
Alternative names for CYP26A1 antibody
Cytochrome P450 26A1, CYP26, Cytochrome P450RAI1, Retinoic acid-metabolizing cytochrome, P450 retinoic acid-inactivating 1, Retinoic acid 4-hydroxylase
Ncbi ID
NP_000774.2, 9606, NP_000774, NM_000783, NM_057157, NP_031837.2
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP)
Background of CYP26A1 antibody
The cytochrome P450 proteins (CYPs) are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. P450 enzymes are classified into subfamilies based on their sequence similarities. CYP26A1, also referred to as retinoic acid-4-hydroxylase, is a major retinoic acid catabolic enzyme. CYP26A1 plays an important role in protecting tailbud tissues from inappropriate exposure to retinoic acid. CYP26A1 transcription is epigenetically regulated by nuclear retinoic acid receptors 2. Mutations in the gene encoding for CYP26A1 are associated with caudal agenesis and spina bifida, imperforate anus, agenesis of the caudal portions of the digestive and urogenital tracts, and malformed lumbosacral skeletal elements. CYP26A1 is upregulated in adenomatous polyposis coli mouse adenomas, human FAP adenomas, human sporadic colon carcinomas, and in the intestine of adenomatous polyposis coli(mcr) mutant zebrafish embryos.











Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA311699 | CYP26A1 antibody |
||||||
| Rabbit polyclonal Cytochrome P450 26A1 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA347614 | CYP26A1 antibody |
||||||
| Rabbit Polyclonal Anti-Cytochrome P450 26A1 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA348981 | CYP26A1 antibody |
||||||
| Goat Polyclonal Anti-CYP26A1 Antibody | |||||||
![]() |
Goat | Aff - Purified | Hu | E, ICC/IF, P, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| AP12392PU-N | CYP26A1 antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| AP23113PU-N | CYP26A1 (485-496) antibody |
||||||
![]() |
Goat | Aff - Purified | Elephant, Hu | P |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP316278 | CYP26A1 (transcript variant 1) |
||||
| Recombinant protein of human cytochrome P450, family 26, subfamily A, polypeptide 1 (CYP26A1), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY400267 | CYP26A1 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY409260 | CYP26A1 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC216278L1V | Lenti ORF particles, CYP26A1 (Myc-DDK tagged) - Human cytochrome P450, family 26, subfamily A, polypeptide 1 (CYP26A1), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,060.00
|
|
| OriGene Technologies, Inc. | ||













+1 additional image
